3M: Clinical Trials

126 trials sponsored by 3M, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

78 completed, 24 terminated, 11 withdrawn, 8 unknown. 61 Not applicable, 13 Phase 4, 9 Phase 1, 9 Phase 3, 5 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable61Completed 34, Terminated 18, Unknown 3, Withdrawn 3, Recruiting 2, Enrolling by invitation 1
Phase 413Completed 7, Withdrawn 2, Active not recruiting 1, Recruiting 1, Terminated 1, Unknown 1
Phase 19Completed 6, Unknown 2, Withdrawn 1
Phase 39Completed 7, Terminated 1, Withdrawn 1
Phase 25Completed 4, Unknown 1
Early Phase 11Completed 1

Follow 3M: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effectiveness of 3M Cavilon Advanced Skin Protectant in the Treatment of Moisture-associated Skin Damage in Hospitals
3M Cavilon Advanced Skin Protectant, Standard hospital wound treatment protocol - Irritant Dermatitis, Stoma Site Dermatitis
Not applicableEnrolling by invitationUniversity Ghent362025-01-272025-12-17
NPWT Reduction Mammaplasty
Prophylactic ciNPWT, Standard Adhesive Dressing - Healthy, Macromastia
Not applicableRecruitingMedstar Health Research Institute922024-12-172025-10-27
3M™ Topical Tissue Adhesive Versus Commercially Available Tissue Adhesive for the Closure of Lacerations and Incisions
3M Topical Tissue Adhesive, Histoacryl® Blue Topical Skin Adhesive - Trauma-related Wound, Surgical Incision
TerminatedSolventum US LLC782024-10-282026-07-27
CiNPWT Lower Extremity Amputations (Closed Incision Neagtive Pressure Wound Therapy)
Standard of Care group, CINPWT - Wound Heal, Wound Dehiscence
Phase 1WithdrawnUniversity of Southern California2024-07-252026-01-16
Povidone Iodine Nasal Application to Prevent Intraoperative Spread of SARS-CoV-2
Povidone Iodine 5% Soln,Top,Kit - SARS-CoV-2 Acute Respiratory Disease
Phase 4WithdrawnUniversity of Iowa2024-07-032023-11-18
A Study to Evaluate the Safety and Immunogenicity of 2 Doses of 100µg BG505 SOSIP.664 gp140 Vaccine, Adjuvanted, Given to a Population of Adults Who Have Received 3 Doses of 300µg BG505 SOSIP.GT1.1 gp140 Vaccine, Adjuvanted
BG505 SOSIP.664 gp140 Vaccine, Adjuvanted (3M-052 AF plus alum) Dosage - Hiv
Phase 1UnknownInternational AIDS Vaccine Initiative82024-04-162024-06-11
Bioaerosol Sampling Device (BSD) Clinical Study
COVID-19
UnknownCantor BioConnect, Inc.3302023-07-102023-09-21
3M Veraflo™ Cleanse Choice Complete™ (VFCCC) Clinical Study
Wound and per-wound assessments While using Device - WOUNDS INJURIES
Not applicableWithdrawnSolventum US LLC2023-06-012024-10-01
Prevena Spine for Use in Spine Surgery
Prevena Plus 125 Therapy Unit, Spine surgery - Surgery, Incision, Surgical
Phase 4CompletedNorthwestern University1042022-12-012026-10-23
NPWTi on Closure of Chronic Pressure Sores
V.A.C.Ulta™ Negative Pressure Wound Therapy System, Standard of Care (Wet-to-dry dressings) - Pressure Sore
Phase 4RecruitingNorthwestern University622022-09-262026-03-25
VAC Bioburden Wound Care Assessment
Wound Vac is applied - Upper Extremity Wound, Lower Extremity Wound
Not applicableTerminatedDuke University52021-08-012023-11-03
Comparing CHG I.V. Securement Dressing With Transparent Dressing for Evaluation of Antimicrobial Efficacy
3M™ Tegaderm™ CHG I.V. Securement Dressing, 3M™ Tegaderm™ Transparent Film Dressing 1626W - Central Venous Catheter Exit Site Infection, Catheter-Related Infections
Not applicableTerminatedSolventum US LLC1232021-05-142024-10-16
Treatment of Deep Carious Lesions With Selective Caries Removal, Partial or Full Pulpotomy
Selective Caries Removal with Biodentine™, Partial Pulpotomy with Biodentine™, Full Pulpotomy with Biodentine™ - Irreversible Pulpitis, Reversible Pulpitis
Not applicableUnknownCharite University, Berlin, Germany2492021-04-012021-03-19
Medical Adhesive Repeat Application Study
Healthy
CompletedSolventum US LLC562021-03-082024-10-01
Epidermal Skin Grafts to Improve Healing In Radiation Wounds
CelluTomeTM Epidermal Harvesting System - Radiation Dermatitis
Not applicableRecruitingMassachusetts General Hospital342021-01-192023-10-23
Evaluating Edema and Range of Motion Using Negative Pressure Therapy vs. Standard Surgical Dressing in Bilateral TKA
Closed Incision Negative Pressure Therapy (ciNPT), Standard Silver-containing Dressing - Surgical Wound, Bilateral Total Knee Arthroplasty
Not applicableTerminatedSolventum US LLC102020-11-062024-10-01
ABTHERA ADVANCE™ Use Without Wittman Patch
Using ABTHERA Advance without a Wittmann Patch - Necrotizing Pancreatitis
CompletedWake Forest University Health Sciences32020-10-122023-08-31
Nasal Decolonization of Dialysis Patients Noses
Povidone-Iodine Topical Ointment, Standard Care - Staphylococcus Aureus Infection
Phase 4Active not recruitingMarin L. Schweizer, PhD3022020-09-292023-06-28
Clinical Performance of Chairside CAD/CAM Restorations
Lithium disilicate onlays (IPS emaxCAD/Ivoclar), Chairside zirconia crowns (3M) - Dental Cements, Caries,Dental
Not applicableCompletedSolventum US LLC582020-08-262025-03-24
Phase I/II Trial of Povidone-iodine (PVP-I) Nasal Swab For Preventing COVID-19 Spread in Healthy Subjects
Povidine iodine nasal swabs - Covid19, Povidone Iodine Adverse Reaction
Phase 1 / Phase 2UnknownBrigham and Women's Hospital502020-08-012020-08-12

Showing 20 of 126. Sign in to see all of them.

Conditions studied

Wounds and Injuries (9)  ·  Dental Caries (8)  ·  Hypothermia (7)  ·  Infections (5)  ·  Respiratory Aspiration (5)  ·  Surgical Wound (5)  ·  Surgical Wound Infection (5)  ·  Varicose Ulcer (5)  ·  Ulcer (4)  ·  Diabetic Foot (3)  ·  Malocclusion (3)  ·  Pressure Ulcer (3)  ·  Sepsis (3)  ·  Bicuspid Aortic Valve Disease (2)  ·  COVID-19 (2)

Interventions

chlorhexidine gluconate (8)  ·  Ethanol (7)  ·  2-Propanol (5)  ·  Chromogranins (5)  ·  Saline Solution (4)  ·  Sodium Chloride (4)  ·  Tiotropium Bromide (4)  ·  DuraPrep (3)  ·  Imiquimod (2)  ·  Standard of Care (2)  ·  Water (2)  ·  Bandages (1)  ·  Chlorhexidine (1)  ·  Collagenases (1)  ·  Control Groups (1)

Countries

United States (75)  ·  United Kingdom (10)  ·  Canada (8)  ·  Germany (8)  ·  Belgium (6)  ·  Netherlands (5)  ·  China (4)  ·  France (3)  ·  Spain (3)  ·  Italy (2)  ·  Romania (2)  ·  Australia (1)  ·  Austria (1)  ·  Brazil (1)  ·  Bulgaria (1)

Top investigators

Gary L Grove, PhD (4)  ·  Dimitri Beeckman, PhD (3)  ·  Muhammad H Bashir, MD, CCRP (3)  ·  Victoria Sessions, PhD (3)  ·  Dennis Fasbinder, DDS (2)  ·  Pui Leung, MD (2)  ·  Rozalia Olsavszky, MD (2)  ·  Abhishek Deshpande, MD, PhD (1)  ·  Andrew M Tang, MD (1)  ·  Andrew W Kirkpatrick, MD (1)  ·  Ariane F Machado Avelar, PhD (1)  ·  B. H. Gerald Rogers, M. D. (1)  ·  Brad Herman, DDS (1)  ·  Brenda C Coalwell, BA (1)  ·  Carlos Higuera, MD (1)

Results publications

PMID 11548680, PMID 19374674, PMID 21362084, PMID 22193141, PMID 22431712, PMID 22543232, PMID 22572899, PMID 23414763, PMID 23680127, PMID 24915210, PMID 25322531, PMID 25332792, PMID 25536308, PMID 25693138, PMID 26237643, PMID 26929286, PMID 27175284, PMID 27456299, PMID 28277409, PMID 28514979, PMID 29382400, PMID 29872966, PMID 30193571, PMID 30230375, PMID 30384932, PMID 31536201, PMID 31818338, PMID 32960242, PMID 33416292, PMID 33761757, PMID 34862278, PMID 35550716, PMID 39603331, PMID 41635193

NIH funding

2015 (1), R01HD086007 (1)